European Archives - Page 782 of 1116 - European Medical Journal

The Changing Landscape of Psoriasis: New Horizons for Oral Therapies

Prof Boehncke opened the symposium and highlighted the changing landscape of psoriasis management. On behalf of Prof Mrowietz, who was unable to attend…

EMJ Dermatology 6 [Suppl 2] 2018

This symposium took place on 14th September 2017, as part of the 26th European Academy of Dermatology and Venerology (EADV) Congress held in Geneva…

More Awareness Needed of Fungal Infection that Affects a Large Number of Women

Recurrent vulvovaginal thrush affects around 138 million women worldwide, a figure that is estimated to rise to 158 million by 2030 according to an…

Psoriasis: From Gene to Clinic

Substantial developments over the last decade have advanced our knowledge and understanding of psoriasis, from both a basic scientific and clinical…

European Medical Journal Presents: EMJ Neurology 6.1

The publication of EMJ Neurology 6.1 is now available, presenting a full review of the European Academy of Neurology (EAN) 2018 Congress…

Review of the 4th European Academy of Neurology Congress 2018

The 4th European Academy of Neurology (EAN) congress was held in the hilly, coastal capital of Lisbon, Portugal, on the 16th–19th June 2018.

Diagnosing Neuromuscular Diseases

The field of neuromuscular diseases (NMD) has evolved at an unprecedented speed over the last two decades. Due to advances in molecular genetics…

EMJ Neurology 6.1 2018

The publication of EMJ Neurology 6.1 is now available, presenting a full review of the European Academy of Neurology (EAN) 2018 Congress, this year held…

Treatment for Rare Genetic Disease Provides Hope for Thousands

A treatment for the very rare genetic disease alkaptonuria (AKU) has been identified by a research collaboration involving the University of Liverpool…

Neuropsychological and Brain Grey Matter Volume Changes After Computer-Assisted Cognitive Treatment in Patients with Multiple Sclerosis

Cognitive impairment is a common disorder in multiple sclerosis (MS), present in >65% of patients both in the early and advanced phases of the disease…